PharmaTimes

GSK close to selling bloodthinners to Aspen

GlaxoSmithKline says it has received an offer for its thrombosis drugs Arixtra and Fraxiparine from South Africa's Aspen Pharmacare, which is also looking to buy the facility in France where the treatments are produced

...more World News

UK website sells unlicensed polypill for heart attack prevention

A new polypill designed to reduce the risk of heart attacks and strokes in healthy patients has gone on sale in the UK over the internet this week, despite not being specifically licensed for this use.

...more UK News

Restorative authorship proposed for unpublished trials

Unpublished or misreported clinical trials whose data have entered the public domain should be made available to other “responsible” researchers for publication or formal correction through medical journals if the sponsors do not agree to set the record straight themselves, campaigners for data transparency propose.

...more Clinical News

World News

GSK close to selling bloodthinners to Aspen

GlaxoSmithKline says it has received an offer for its thrombosis drugs Arixtra and Fraxiparine from South Africa's Aspen Pharmacare, which is also looking to buy the facility in France where the treatments are produced
AstraZeneca reveals site for new global HQ in Cambridge

AstraZeneca has confirmed that it will build a global R&D centre and new corporate headquarters at the Cambridge Biomedical Campus in the UK city
Royalty pulls out so who will buy Elan?

Royalty Pharma has finally abandoned its $8 billion bid for Elan Corp, leaving observers to wonder who will make an offer for the Irish drugmaker which put itself up for sale last week
Astellas looks to divest dermatology assets: Reuters

Astellas Pharma is weighing up the possibility of selling its dermatology portfolio, which could be worth between $500 million and $1 billion, according to a report published by Reuters
Teva buys respiratory specialist MicroDose Therapeutx

As part of plans to expand its respiratory franchise, Teva Pharmaceutical Industries is to acquire the USA's MicroDose Therapeutx in a deal that could be worth $165 billion

UK News

CQC "getting out of the enforcement business"

The Care Quality Commission (CQC) is changing from "top to bottom," and moving from being part of the system responsible for improvement to become, "above all else, being on the side of people who use services," according to Dr Paul Bate, director of strategy and intelligence at the Commission.
NHS England calls for public input in urgent care review

NHS England has put out a call to the public and NHS staff for input into an ongoing review of urgent care and emergency services.
UK website sells unlicensed polypill for heart attack prevention

A new polypill designed to reduce the risk of heart attacks and strokes in healthy patients has gone on sale in the UK over the internet this week, despite not being specifically licensed for this use.
Cervical cancer cases slashed with HPV test

Around a third of cervical cancer cases could be prevented every year in England if women were tested for human papilloma virus, researchers are claiming.

Clinical News

Restorative authorship proposed for unpublished trials

Unpublished or misreported clinical trials whose data have entered the public domain should be made available to other “responsible” researchers for publication or formal correction through medical journals if the sponsors do not agree to set the record straight themselves, campaigners for data transparency propose.
PatientsLikeMe, inVentiv partner to accelerate recruitment

Online patient network PatientsLikeMe has teamed up with inVentiv Health, the US-based provider of clinical development, commercialisation and consulting services, to accelerate patient recruitment for clinical trials.
ICON, UCD launch graduate certificate in clinical research

ICON, the global provider of outsourced development services based in Dublin, Ireland, has further consolidated its strategic relationship with University College Dublin (UCD) by teaming up on a new graduate certificate in clinical research.